Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 9, 2023. (Total: 223907Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Achievement and WT1[original query]
Core binding factor acute myeloid leukaemia and c-KIT mutations.
Oncology reports 2013 May 29 (5): 1867-72.
Riera Ludovica, Marmont Filippo, Toppino Daniela, Frairia Chiara, Sismondi Francesca, Audisio Ernesta, Di Bello Cristiana, D'Ardia Stefano, Di Celle Paola Francia, Messa Emanuela, Inghirami Giorgio, Vitolo Umberto, Pich Achil
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin.
Oncotarget 2014 Aug 5 (15): 6280-8.
Lambert Juliette, Lambert Jérôme, Nibourel Olivier, Pautas Cécile, Hayette Sandrine, Cayuela Jean-Michel, Terré Christine, Rousselot Philippe, Dombret Hervé, Chevret Sylvie, Preudhomme Claude, Castaigne Sylvie, Renneville Ali
High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy.
Medical science monitor : international medical journal of experimental and clinical research 2018 2 24 758-767.
Qin Ya-Zhen, Zhao Ting, Zhu Hong-Hu, Wang Jing, Jia Jin-Song, Lai Yue-Yun, Zhao Xiao-Su, Shi Hong-Xia, Liu Yan-Rong, Jiang Hao, Huang Xiao-Jun, Jiang Qi
WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia.
Clinical lymphoma, myeloma & leukemia 2020 Aug .
Šálek Cyril, Vydra Jan, Cerovská Ela, Šestáková Šárka, Ransdorfová Šárka, Válková Veronika, Cetkovský Petr, Remešová Ha
High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk.
Clinical and experimental medicine 2023 1 .
Xu Nan, Chen Wen-Min, Li Ling-Di, Long Ling-Yu, Wang Xu, Jiang Qian, Jiang Hao, Huang Xiao-Jun, Qin Ya-Zh
TOP